Cabaletta Bio, Inc. · NASDAQ:CABA
Cormorant Asset Management, LP reported a 9.28% stake in Cabaletta Bio, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Cormorant Asset Management, LP reported a 9.28% stake in Cabaletta Bio, Inc., 9,400,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 9.28%
- Shares
- 9,400,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Cormorant Asset Management, LP | 9.28% | 9,400,000 |
| Bihua Chen | 9.28% | 9,400,000 |
Source
Related
- Cabaletta Bio, Inc.
- Cormorant Asset Management, LP
- Cabaletta Bio, Inc. shareholders
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · May 15, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · Nov 14, 2025
- Schedule 13G · Cormorant Asset Management, LP · Aug 14, 2025
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities III, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G · Norges Bank · Aug 12, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026